Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Miao, Lili ^a,b   Chen, Wei ^a   Zhou, Ling ^a   Wan, Huanying ^a   Gao, Beili ^a   Feng, Yun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b YiZheng People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84962209773     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21359     Document Type: Article

References (30)

1. Lever, A. F. et al. inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet. 352, 179-184 (1998).
2. Friis, S. et al. Angiotensin-converting enzyme inhibitors and the risk of cancer: A populationbased cohort study in Denmark. Cancer. 92, 2462-2470 (2001).
3. Meier, C. R., Derby, L. E., Jick, S. S. & Jick, H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med. 160, 349-353(2000).
4. Lindholm, L. H. et al. Relation between drug treatment and cancer in hypertensives in the Swedish trial in old patients with hypertension 2: A 5-year, prospective, randomised, controlled trial. Lancet. 358, 344-539 (2001).
5. Pasternak, B., Svanström, H., Callréus, T., Melbye, M. & Hviids, A. Use of angiotensin receptor blockers and the risk of cancer. Circulation. 123, 1729-1736 (2011).
6. Chang, C. H., Lin, J. W., Wu, L. C. & Lai, M. S. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: A nationwide case-control study. J Clin Oncol. 29, 3001-3007(2011).
7. Coleman, C. I., Baker, W. L., Kluger, J. & White, C. M. Antihypertensive medication and their impact on cancer incidence: A mixed treatment comparison meta-analysis of randomized controlled trials. J Hum Hypertens. 26, 622-629(2008).
8. Sipahi, I., Debanne, S. M., Rowland, D. Y., Simon, D. I. & Fang, J. C. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 11, 627-636(2010).
9. Ager, E. I., Neo, J. & Christophi, C. The renin-angiotensin system and malignancy. Carcinogenesis. 29, 1675-1684(2008).
10. Khakoo, A. Y., Sidman, R. L., Pasqualini, R. & Arap, W. Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?Cancer Res. 68, 9112-9115(2008).
11. Greco, S. et al. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol. 196, 370-377(2003).
12. Egami, K. et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest. 112, 67-75(2003).
13. Fujita, M., Hayashi, I., Yamashina, S., Itoman, M. & Majima, M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res. 294, 441-447(2002).
14. Neo, J. H., Malcontenti-Wilson, C., Muralidharan, V. & Christophi, C. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol. 22, 577-584(2007).
15. Feng, Y. et al. Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro. Oncol Rep. 26, 1157-1164(2011).
16. Seung, T. K. et al. How Does Inhibition of the Renin-Angiotensin System Affect the Prognosis of Advanced Gastric Cancer Patients Receiving Platinum-Based Chemotherapy? Oncology. 83, 354-360(2012).
17. Ganz, P. A., Habel, L. A., Weltzien, E. K., Caan, B. J. & Cole, S. W. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 129, 549-556(2011).
18. Heinzerling, J. H., Anthony, T., Livingston, E. H. & Huerta, S. Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. Am Surg. 73, 230-238(2007).
19. Ronquist, G., Frithz, G., Wang, Y. & Lindeborg, T. Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer. Scand J Urol Nephrol. 43, 32-36(2009).
20. Chen, X. et al. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett. 328, 318-324(2013).
21. Wang, L. et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. Chin Med J (Engl). 121, 2167-2171(2008).
22. Deshayes, F. & Nahmias, C. Angiotensin receptors: A new role in cancer?Trends Endocrinol Metab. 16, 293-299(2005).
23. Uemura, H. et al. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther. 2, 1139-1147(2003).
24. Ciardiello, F. & Tortora, G. EGFR antagonists in cancer treatment. N Engl J Med. 358, 1160-1174(2008).
25. Greco, S. et al. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol. 196, 370-377(2003).
26. Nakai, Y. et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer. 103, 1644-1648 (2010).
27. Kedika, R. et al. Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol. 45, e12-e16(2011).
28. Nakai, Y. et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer. 103, 1644-1648 (2011).
29. Wilop, S. et al. Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line Platinum-based chemotherapy. J Cancer Res Clin Oncol. 135, 1429-1435(2009).
30. Nakai, Y. et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer, 103, 1644-1648 (2010).